Kayhan Tetik Burcu, Gedik Tekinemre Işılay, Taş Servet
Department of Family Medicine, Inonu University Medical Faculty, Malatya, Turkey.
, Elazığ Health Directorate, Elazığ, Turkey.
J Community Health. 2021 Jun;46(3):471-475. doi: 10.1007/s10900-020-00880-2.
The coronavirus pandemic first started in Wuhan, China, in December 2019 and affected the whole world. In our country, new measures to be taken were announced after the first case was seen on March 11, 2020. In this study, patients who admitted to the smoking cessation clinic in 2018 and followed up by phone, regarding smoking cessation status in 2019 were questioned for their smoking cessation status after the coronavirus pandemic in 2020. In this descriptive study, the patients who applied to the smoking cessation outpatient clinic in 2018 were questioned regarding their smoking cessation status after 1 year and after the pandemic. It was investigated whether coronapandemia had an effect on smoking cessation. The data were evaluated by using SPSS 22 software. A value of p < 0.05 was considered significant. A total of 357 individuals with a median of Fagerström score of 7.0 were included in the study. Seventy-one (19.9%) of the subjects used nicotine tape, 268 (75.1%) used varenicline, and 18 (5.0%) used both. When the success of those who quit smoking before pandemic and those who quit smoking after pandemic were compared, a statistically significant relationship was found (p < 0.001). In our study, the rate of smoking cessation after 1 year was 23.7%, and the most common side effects were psychiatric complaints, whereas the rate of smoking cessation during the pandemic period was 31.1%. In order to increase the rate of smoking cessation, which is an important public health problem, more counseling should be provided, during the pandemic period.
冠状病毒大流行于2019年12月首次在中国武汉爆发,并蔓延至全球。在我国,2020年3月11日出现首例病例后,政府宣布了一系列新措施。本研究对2018年就诊于戒烟门诊并接受电话随访的患者进行调查,询问他们在2019年的戒烟情况以及2020年冠状病毒大流行后的戒烟情况。在这项描述性研究中,我们对2018年就诊于戒烟门诊的患者进行了为期1年及疫情后的随访,询问其戒烟情况,并调查新冠疫情是否对戒烟产生影响。数据采用SPSS 22软件进行评估,p值<0.05被认为具有统计学意义。共有357名个体纳入研究,Fagerström评分中位数为7.0。其中71名(19.9%)使用尼古丁贴片,268名(75.1%)使用伐尼克兰,18名(5.0%)两者都用。比较疫情前戒烟者和疫情后戒烟者的成功率,发现有统计学显著差异(p<0.001)。在本研究中,1年后的戒烟率为23.7%,最常见的副作用是精神方面的不适,而疫情期间的戒烟率为31.1%。为提高戒烟率这一重要的公共卫生问题,在疫情期间应提供更多的咨询服务。